|
 |
About our
President
Stuart B Levy, MD,
Professor of Medicine and of Molecular Biology and Microbiology, is the Director
of the Center for Adaptation Genetics and Drug Resistance at Tufts University School
of Medicine and Staff Physician at the New England Medical Center. He also serves
as President of the Alliance for the Prudent Use of Antibiotics, an international
organization with members in over 90 countries of the world.
A magna cum laude, Phi Beta Kappa graduate of Williams College, Dr. Levy received
his medical degree from the University of Pennsylvania. He did his residency at Mt.
Sinai Hospital in New York and postdoctoral research at the National Institutes of
Health, Bethesda.
Dr. Levy is well known for his contributions to the antibiotic resistance field.
He has published over 200 papers on antibiotic use and resistance, and has edited
three books and two special journal editions devoted to the subject. His 1992 book,
The
Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle, has been cited widely in both the
lay and scientific media. It presents the conflicting consequences of antibiotic
use--curing disease and selecting resistant bacteria. In the book he stresses increased
awareness of the problems of antibiotic misuse and resistance, and outlines an approach
towards improving antibiotic usage and efficacy worldwide.
Dr. Levy led the discovery of the first characterized energy-dependent antibiotic
efflux mechanism and efflux protein, that for tetracycline resistance. He has written
extensively about efflux as a mechanism for drug resistance. His interests have expanded
to the phenomenon of multidrug resistance in bacterial and mammalian cells, including
the discovery of a regulatory locus mar for intrinsic multiple antibiotic
resistance/susceptibility among the Enterobacteriaceae and new efflux systems
for chemotherapeutic agents among mammalian cells.
Dr. Levy is a Fellow of the American College of Physicians, Infectious Disease Society
of America, and the American Academy of Microbiology. He has organized and chaired
four international meetings on drug resistance and was Chairperson of the US Fogarty
Center three-year international study of "Antibiotic use and resistance worldwide".
He has been, and continues to be, a consultant to international and national organizations
and agencies, including the World Health Organization in Geneva and Southeast Asia,
the US FDA and US EPA. He is an Editor of Plasmid and serves on a number of
Editorial Boards, including Antimicrobial Agents & Chemotherapy.
He has been a Lecturer for the American Society for Microbiology Foundation and the
Australia Society for Microbiology. He has served twice as a member of the Comite
Scientifique díEvaluation of the Pasteur Institut, Paris. He was a member of the
Advisory Panel for the US Office of Technology Assessment report on antibiotic resistant
bacteria. He was awarded the 1995 Hoechst-Roussel Award for esteemed research in
antimicrobial chemotherapy by the American Society for Microbiology. He is the President
of the American Society for Microbiology.
Dr. Levy has been featured and quoted for his work on antibiotic use and resistance
in major national and international newspapers and magazines including Time,
Newsweek, US News and World Report, New Yorker, New
York Times, Washington Post, USA Today, Chicago Tribune,
and San Francisco Chronicle. He has appeared on Good Morning America,
Nova, the Today Show, Fox Front Page, ABC Prime Time,
CBS 48 Hours, CNN, Canadian national television, Japanese public television,
and all major US television network news shows. He was featured in the March 28,
1994, Newsweek cover story on antibiotic resistance. More recently, he appeared
on CBS This Morning and the Jim Lehrer News Hour. |
|
|
